Literature DB >> 9705235

Molecular pathophysiology of cystic fibrosis based on the rescued knockout mouse model.

J C Cohen1, S L Morrow, R J Cork, J B Delcarpio, J E Larson.   

Abstract

Cystic fibrosis transmembrane conductance regulator (cftr) gene mutations are thought to result in cystic fibrosis due to an absence of the protein's chloride channel. Recently, the lethal intestinal blockage in the cftr knockout mouse was reversed by a single in utero dose of a recombinant adenovirus containing the human cftr gene. The rescue of these animals did not require continuous expression of the gene and the cAMP-dependent chloride channel was not permanently restored. These data suggested that cftr was required for normal development of the intestine but not for normal function of the adult organ. Phenotypic changes in the intestines and lungs of in utero cftr-treated knockout and heterozygous mice revealed that altered development was induced. The intestines of the untreated knockout mice were shown to be deficient in both intracellular calcium and UTP receptors. Both of these deficiencies were partially corrected in the rescued knockout mice, whereas treatment of heterozygous animals disrupted the normal pattern of these markers. Examination of the lungs of knockout cftr (-/-) mice with lectins showed an increase in secreted glycoconjugates containing alpha(2,6)-sialic acid and fucose as compared with control heterozygotes. The in utero-treated knockouts showed an increase in this material as well, but it was contained in intracellular vesicles. Electron microscopy of these tissues confirmed the developmental alteration of secretory cell differentiation in the lungs. These data show that cftr is required in both the lung and intestines for normal differentiation of a secretory cell population and that in its absence these cells fail to develop properly. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705235     DOI: 10.1006/mgme.1998.2683

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  14 in total

1.  In utero gene therapy.

Authors:  J E Larson; J C Cohen
Journal:  Ochsner J       Date:  2000-04

2.  Biosynthesis of mucin type O-glycans: lack of correlation between glycosyltransferase and sulfotransferase activities and CFTR expression.

Authors:  I Brockhausen; F Vavasseur; X Yang
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

Review 3.  Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.

Authors:  A D Rhim; L Stoykova; M C Glick; T F Scanlin
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

4.  Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Authors:  N Peretti; V Marcil; E Drouin; E Levy
Journal:  Nutr Metab (Lond)       Date:  2005-05-03       Impact factor: 4.169

5.  High resolution ultrasound-guided microinjection for interventional studies of early embryonic and placental development in vivo in mice.

Authors:  John C Slevin; Lois Byers; Marina Gertsenstein; Dawei Qu; Junwu Mu; Nana Sunn; John C P Kingdom; Janet Rossant; S Lee Adamson
Journal:  BMC Dev Biol       Date:  2006-02-27       Impact factor: 1.978

6.  Transient in utero knockout (TIUKO) of C-MYC affects late lung and intestinal development in the mouse.

Authors:  J Craig Cohen; Donald K Scott; James Miller; Jianxuan Zhang; Pengbo Zhou; Janet E Larson
Journal:  BMC Dev Biol       Date:  2004-04-16       Impact factor: 1.978

7.  Adult onset lung disease following transient disruption of fetal stretch-induced differentiation.

Authors:  Joseph J Hudak; Erin Killeen; Ashok Chandran; J Craig Cohen; Janet E Larson
Journal:  Respir Res       Date:  2009-05-06

8.  The Peter Pan paradigm.

Authors:  J Craig Cohen; Janet E Larson
Journal:  Theor Biol Med Model       Date:  2008-01-08       Impact factor: 2.432

9.  In utero recombinant adeno-associated virus gene transfer in mice, rats, and primates.

Authors:  Deiadra J Garrett; Janet E Larson; Daisy Dunn; Luis Marrero; J Craig Cohen
Journal:  BMC Biotechnol       Date:  2003-09-30       Impact factor: 2.563

10.  Long term physiologic modification using rAAV in utero gene-therapy.

Authors:  Deiadra J Garrett; J Craig Cohen; Janet E Larson
Journal:  Genet Vaccines Ther       Date:  2004-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.